• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Mountain Crest Acquisition Corp. II

    4/16/21 4:44:40 PM ET
    $MCAD
    Finance
    Get the next $MCAD alert in real time by email
    SC 13G 1 formsc13g.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. __N/A____)*

     

    Mountain Crest Acquisition Corp. II

     

    (Name of Issuer)

     

    Common Stock

     

    (Title of Class of Securities)

     

    62402D204

     

    (CUSIP Number)

     

    January 8, 2021

     

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [  ] Rule 13d-1(b)

    [X] Rule 13d-1(c)

    [  ] Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     
     

     

    CUSIP No. 62402D204

     

    1.

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Boothbay Absolute Return Strategies, LP

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (see instructions)

    (a) [  ]

    (b) [X]

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.  

    SOLE VOTING POWER

     

    0

    6.  

    SHARED VOTING POWER

     

    349,579 *

    7.  

    SOLE DISPOSITIVE POWER

     

    0

    8.  

    SHARED DISPOSITIVE POWER

     

    349,579 *

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    349,579 *

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (see instructions) [  ]

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    5.29%*

    12.

    TYPE OF REPORTING PERSON (see instructions)

     

    PN

     

     
     

     

    CUSIP No. 62402D204

     

    1.

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Boothbay Fund Management, LLC

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (see instructions)

    (a) [  ]

    (b) [X]

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.  

    SOLE VOTING POWER

     

    0

    6.  

    SHARED VOTING POWER

     

    416,166 *

    7.  

    SOLE DISPOSITIVE POWER

     

    0

    8.  

    SHARED DISPOSITIVE POWER

     

    416,166 *

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    416,166 *

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (see instructions) [  ]

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    6.30%*

    12.

    TYPE OF REPORTING PERSON (see instructions)

     

    IA, OO

     

     
     

     

    CUSIP No. 62402D204

     

    1.

    NAMES OF REPORTING PERSONS

    I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

    Ari Glass

    2.

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (see instructions)

    (a) [  ]

    (b) [X]

    3.

    SEC USE ONLY

     

    4.

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    United States

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY

    EACH

    REPORTING

    PERSON WITH

    5.  

    SOLE VOTING POWER

     

    0

    6.  

    SHARED VOTING POWER

     

    416,166 *

    7.  

    SOLE DISPOSITIVE POWER

     

    0

    8.  

    SHARED DISPOSITIVE POWER

     

    416,166 *

    9.

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    416,166 *

    10.

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    (see instructions) [  ]

    11.

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    6.30%*

    12.

    TYPE OF REPORTING PERSON (see instructions)

     

    IN, HC

     

     
     

     

    Item 1.

     

      (a)

    Name of Issuer

    Mountain Crest Acquisition Corp. II (the “Issuer”)

         
      (b)

    Address of Issuer’s Principal Executive Offices

    311 West 43rd Street, 12th Floor

    New York, NY 10036

     

    Item 2.

     

      (a)

    Name of Person Filing:

    Boothbay Absolute Return Strategies, LP*

    Boothbay Fund Management, LLC*

    Ari Glass*

         
      (b)

    Address of the Principal Office or, if none, residence

    140 East 45th Street, 14th Floor

    New York, NY 10017

         
      (c)

    Citizenship

    Boothbay Absolute Return Strategies, LP – Delaware

    Boothbay Fund Management, LLC – Delaware

    Ari Glass – United States

         
      (d)

    Title of Class of Securities

    Common Stock

         
      (e)

    CUSIP Number

    62402D204

     

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: N/A

     

    Item 4. Ownership.

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

      (a)

    Amount beneficially owned:

     

    Boothbay Absolute Return Strategies, LP – 349,579 *

    Boothbay Fund Management, LLC – 416,166 *

    Ari Glass – 416,166 *

         
      (b)

    Percent of class:

     

    Boothbay Absolute Return Strategies, LP – 5.61%*

    Boothbay Fund Management, LLC – 6.30%*

    Ari Glass – 6.30%*

     

      (c) Number of shares as to which the person has:
           
        (i)

    Sole power to vote or to direct the vote

    Boothbay Absolute Return Strategies, LP – 0

    Boothbay Fund Management, LLC – 0

    Ari Glass – 0

           
        (ii)

    Shared power to vote or to direct the vote

    Boothbay Absolute Return Strategies, LP – 349,579 *

    Boothbay Fund Management, LLC – 416,166 *

    Ari Glass – 416,166 *

           
        (iii)

    Sole power to dispose or to direct the disposition of

    Boothbay Absolute Return Strategies LP – 0

    Boothbay Fund Management, LLC – 0

    Ari Glass – 0

           
        (iv)

    Shared power to dispose or to direct the disposition of

    Boothbay Absolute Return Strategies, LP – 349,579 *

    Boothbay Fund Management, LLC – 416,166 *

    Ari Glass – 416,166 *

     

    Instruction. For computations regarding securities which represent a right to acquire an underlying security see §240.13d-3(d)(1).

     

     
     

     

    * The Common Stock (the “Shares”) of Mountain Crest Acquisition Corp. II., a blank check company incorporated under the laws of the State of Delware (the “Issuer”), reported herein are held in the form of units (the “Units”). Each Unit consists of one share of one Share and one right. Each right entitles the holder thereof to receive one-tenth of one Share upon the consummation of an initial business combination (“Initial Business Combination”), as described in more detail in the Issuer’s Prospectus filed with the SEC on January 11, 2021 (the “Prospectus”). Each right will become exercisable on the later of one year after the effective date of the Prospectus or the consummation of an Initial Business Combination and will expire five years after the completion of an Initial Business Combination, or earlier upon redemption or liquidation. In accordance with Rule 13d-3(d)(1) regarding securities which represent a right to acquire an underlying security, each Unit has been reported herein as representing the beneficial ownership of one (1) Share.

     

    The Units are held by Boothbay Absolute Return Strategies, LP, a Delaware limited partnership, and one or more other private funds (the “Fund”), which is managed by Boothbay Fund Management, LLC, a Delaware limited liability company (the “Adviser”). The Adviser, in its capacity as the investment manager of the Fund, has the power to vote and the power to direct the disposition of all Units held by the Fund. Ari Glass is the Managing Member of the Adviser. Accordingly, for the purposes of Reg. Section 240.13d-3, the reporting persons herein may be deemed to beneficially own an aggregate of 416,166 Shares, or 6.30% of the 6,605,000 Shares that were issued and outstanding following the issuance made pursuant to the Prospectus.

     

    This report shall not be deemed an admission that the Adviser, the Fund or any other person is the beneficial owner of the securities reported herein for purposes of Section 13 of the Securities Exchange Act of 1934, as amended, or for any other purpose. Each of the reporting persons herein disclaims beneficial ownership of the Shares reported herein except to the extent of the reporting person’s pecuniary interest therein.

     

    Item 5. Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ].

     

    Instruction. Dissolution of a group requires a response to this item.

     

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.

     

    N/A

     

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

     

    N/A

     

    Item 8. Identification and Classification of Members of the Group.

     

    N/A

     

    Item 9. Notice of Dissolution of Group.

     

    N/A

     

    Item 10. Certification.

     

     

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

     

     
     

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: April 16, 2021

     

      Boothbay Absolute Return Strategies, LP
       
     

    By: Boothbay Fund Management, LLC,

    its investment manager

         
      By: /s/ Ari Glass
      Ari Glass, Managing Member
         
      Boothbay Fund Management, LLC
       
      By: /s/ Ari Glass
      Ari Glass, Managing Member
         
      Ari Glass
       
      By: /s/ Ari Glass
      Individually

     

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

     

    Note. Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See s.240.13d-7 for other parties for whom copies are to be sent.

     

    Attention. Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

     

     
     

     

    JOINT FILING STATEMENT

    PURSUANT TO RULE 13D-1(K)(1)

     

    The undersigned hereby consent and agree to the joint filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Shares of Mountain Crest Acquisition Corp. II. together with any or all amendments thereto, when and if required. The parties hereto further consent and agree to file this Joint Filing Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule13G.

     

    This Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.

     

    Dated: April 16, 2021

     

      Boothbay Absolute Return Strategies, LP
       
     

    By: Boothbay Fund Management, LLC,

    its investment manager

         
      By: /s/ Ari Glass
      Ari Glass, Managing Member
         
      Boothbay Fund Management, LLC
       
      By: /s/ Ari Glass
      Ari Glass, Managing Member
         
      Ari Glass
       
      By: /s/ Ari Glass
      Individually

     

     

     

    Get the next $MCAD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MCAD

    DatePrice TargetRatingAnalyst
    7/29/2021$19.00Buy
    Lake Street
    More analyst ratings

    $MCAD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Better Therapeutics Closes Business Combination and Debuts on Nasdaq

      Trading to commence on Nasdaq on Oct. 29, 2021, under the ticker symbol BTTX Better Therapeutics, Inc., a prescription digital therapeutics (PDT) company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the completion of its business combination with Mountain Crest Acquisition Corp II (NASDAQ:MCAD, "Mountain Crest II"))), a publicly traded special purpose acquisition corporation or SPAC. The resulting combined company will commence trading its shares on Nasdaq under the ticker symbol "BTTX" on October 29, 2021. The shareholders of Mountain Crest Acquisition Corp II approved the transaction at a special meeting held on October

      10/29/21 8:00:00 AM ET
      $MCAD
      Finance
    • Mountain Crest Acquisition Corp. II Stockholders Approve Business Combination with Better Therapeutics Inc.

      NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ:MCAD) (the "Company"), a publicly traded special purpose acquisition company, announced today that in a special meeting of stockholders on October 27, 2021, its stockholders voted to approve its proposed business combination (the "business combination") with Better Therapeutics Inc. ("Better Therapeutics"), a company engaged in developing a novel form of cognitive behavioral therapy to address the root causes of cardiometabolic diseases. The business combination is expected to close on October 28, 2021, subject to the satisfaction of certain customary closing conditions. As part of the consummation o

      10/27/21 4:44:29 PM ET
      $MCAD
      Finance
    • Mountain Crest Acquisition Corp. II and Better Therapeutics, Inc. Announce Registration Statement Effectiveness and Scheduled Special Meeting to Approve Business Combination on October 27, 2021

      NEW YORK and SAN FRANCISCO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Mountain Crest Acquisition Corp. II (NASDAQ:MCAD, "Mountain Crest II"))), a publicly-traded special purpose acquisition company and Better Therapeutics, Inc. ("Better Therapeutics"), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address root causes of cardiometabolic diseases, today announced that MCAD's registration statement on Form S-4 (File No. 333-255493) relating to the previously announced merger of MCAD and Better Therapeutics has been declared effective by the U.S. Securities and Exchange Commission as of October 12, 2021. MCAD also announced that it will hold its special m

      10/12/21 8:00:04 PM ET
      $MCAD
      Finance

    $MCAD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3: New insider Heinen Mark claimed ownership of 6,667 shares

      3 - Better Therapeutics, Inc. (0001832415) (Issuer)

      11/1/21 8:35:22 PM ET
      $MCAD
      Finance
    • SEC Form 4: Perry David P bought $2,512,432 worth of shares (251,536 units at $9.99) and was granted 10,578,501 shares

      4 - Better Therapeutics, Inc. (0001832415) (Issuer)

      11/1/21 8:55:45 PM ET
      $MCAD
      Finance
    • SEC Form 3: New insider Parker Geoffrey M. claimed ownership of 33,333 shares

      3 - Better Therapeutics, Inc. (0001832415) (Issuer)

      11/1/21 8:30:59 PM ET
      $MCAD
      Finance

    $MCAD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by Mountain Crest Acquisition Corp. II

      SC 13D - Better Therapeutics, Inc. (0001832415) (Subject)

      11/8/21 5:28:53 PM ET
      $MCAD
      Finance
    • SEC Form SC 13D filed by Mountain Crest Acquisition Corp. II

      SC 13D - Better Therapeutics, Inc. (0001832415) (Subject)

      11/8/21 5:26:04 PM ET
      $MCAD
      Finance
    • SEC Form SC 13G filed by Mountain Crest Acquisition Corp. II

      SC 13G - Better Therapeutics, Inc. (0001832415) (Subject)

      11/8/21 1:11:00 PM ET
      $MCAD
      Finance

    $MCAD
    SEC Filings

    See more
    • Mountain Crest Acquisition Corp. II filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status

      8-K - Better Therapeutics, Inc. (0001832415) (Filer)

      11/3/21 5:26:13 PM ET
      $MCAD
      Finance
    • SEC Form 25-NSE filed by Mountain Crest Acquisition Corp. II

      25-NSE - Mountain Crest Acquisition Corp II (0001832415) (Subject)

      10/28/21 4:10:53 PM ET
      $MCAD
      Finance
    • SEC Form 425 filed by Mountain Crest Acquisition Corp. II

      425 - Mountain Crest Acquisition Corp II (0001832415) (Subject)

      10/27/21 5:21:36 PM ET
      $MCAD
      Finance

    $MCAD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Lake Street initiated coverage on Mountain Crest Acquisition Corp. II with a new price target

      Lake Street initiated coverage of Mountain Crest Acquisition Corp. II with a rating of Buy and set a new price target of $19.00

      7/29/21 9:53:58 AM ET
      $MCAD
      Finance

    $MCAD
    Leadership Updates

    Live Leadership Updates

    See more
    • Better Therapeutics Appoints Dr. Risa Lavizzo-Mourey to its Board of Directors

      Better Therapeutics, Inc., a prescription digital therapeutics company delivering cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Dr. Risa Lavizzo-Mourey to its board of directors; she will also serve as Compensation Committee chair. "Dr. Lavizzo-Mourey brings critical insights into health policy, as well as her background as a primary care physician at a critical juncture for Better Therapeutics," said David Perry, co-founder and chairman of Better Therapeutics. "Her experience and counsel will help us establish our prescription digital therapeutics as the new standard of care for people with cardiometabolic diseases.

      4/20/21 8:00:00 AM ET
      $MRK
      $GE
      $INTC
      $MCAD
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Consumer Electronics/Appliances
      Technology